Biotech ETF Might be Ready to Bounce

Biotechnology stocks and exchange traded funds are struggling to start 2016 with some well-known biotech ETFs residing near 52-week lows and well off the highs set in mid-2015. However, the group’s recent struggles could be giving way to buying opportunities. The SPDR S&P Biotech ETF...